The myxomatosis virus has been affecting rabbits for many years, with a high level of mortality, often being very difficult to control.

In addition to the implementation of strict biosecurity measures, vaccines are an excellent tool for the prevention of this disease.

It is therefore essential to follow good vaccination practice in order to obtain the best results.

MIXOHIPRA-H® and MIXOHIPRA-FSA® are vaccines containing live attenuated virus. It must be kept alive throughout the vaccination process, from receipt until administration.

If the vaccine virus is inactivated, it will have no effect in the rabbit and the animal will not be protected against this important disease.